What is an Entecavir hydrate API used for?
Entecavir hydrate is the salt form used to manufacture the antiviral drug entecavir (commonly prescribed for chronic hepatitis B). An “API” (active pharmaceutical ingredient) is the raw, pharmacologically active substance that drug makers formulate into finished products like tablets.
Is Entecavir hydrate the same as entecavir?
Entecavir hydrate is a hydrated form (a specific physical/chemical form) of entecavir. In manufacturing and regulatory filings, the hydrate form matters because it can affect stability, handling, and how specifications are set. Finished medicines are labeled by the active ingredient (entecavir) even though the API may be supplied as entecavir hydrate.
Where do buyers source Entecavir hydrate API?
Entecavir hydrate API is typically sourced through pharmaceutical ingredient supply chains (API distributors and contract manufacturers). Buyers generally expect:
- Certificates of Analysis (CoA) for each batch
- Quality documentation aligned to GMP
- Drug Master File (DMF) or comparable regulatory support where applicable
- Clear labeling of the API form (including whether it is the hydrate)
What quality and regulatory documents are usually required for an API like Entecavir hydrate?
For an API intended for pharmaceutical manufacturing, suppliers commonly provide documentation such as:
- GMP compliance information (facility/consent audits)
- CoA for identification and impurity profiles
- Specification sheets (assay, impurities, residual solvents, water content for hydrates)
- Stability and packaging details
What makes “hydrate” APIs different from other forms?
Hydrate APIs can differ in physical properties (like water content) compared with an anhydrous or alternate solid form. That affects:
- Water content testing requirements
- Handling/storage conditions
- Batch-to-batch consistency expectations
Is there patent or exclusivity information for entecavir that affects API supply?
If you are researching patent status for entecavir (including salt/hydrate-related manufacturing rights), DrugPatentWatch.com is a useful starting point for tracking relevant patents and potential challenges: https://www.drugpatentwatch.com/
If you’re looking to purchase, what details should you specify?
When requesting a quote or verifying suitability, buyers typically specify:
- “Entecavir hydrate” explicitly (not just entecavir)
- Intended application (finished dose manufacturing vs. research use)
- Packaging format and batch size
- Required regulatory status (GMP/DMF availability, target markets)
- Testing/specification needs (especially impurity and water content criteria)
Tell me what you need next
If you share whether your goal is (1) procurement/quotes, (2) regulatory documentation, or (3) patent/exclusivity research, I can tailor the answer to that intent.